Biomode SA, founded in 2010 and headquartered in Portugal, is an innovative company focused on rapid pathogen detection in food and clinical samples. The company's proprietary product series, PROBE4®, utilizes PNA-FISH technology to enable rapid, accurate, and color-based pathogen identification. The company's kits, designed for reliable detection of microorganisms, aim to provide confidence in pathogen identification. In July 2018, the company received a €71.43K grant investment from EASME - EU Executive Agency for SMEs. Biomode operates in the Biotechnology, Health Care, Life Sciences, and Medical Devices industries, offering innovative solutions for pathogen detection through its PROBE4® kits.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | €71.43K | 1 | EASME - EU Executive Agency for SMEs | 01 Jul 2018 |
| Series A | €1.60M | 4 |
|
19 Mar 2015 |
| Seed Round | €300.00K | 1 |
|
20 Dec 2010 |
No recent news or press coverage available for Biomode SA.
We care about your data, and we'd love to use cookies make your experience better.
